Drugs that affect autonomic functions or the extrapyramidal system

T Nakaki - Side Effects of Drugs Annual, 2019 - Elsevier
The adverse effects of drugs that affect autonomic functions or the extrapyramidal system are
reviewed based on literature published mainly from January, 2018 to December, 2018 …

Bromocriptine/cabergoline/oxcarbazepine interaction

R Krysiak - Reactions, 2012 - Springer
The woman was increased to a daily dose of 7.5 mg of bromocriptine for treatment of a
prolactin-secreting prolactinoma. Her prolactin level improved after 2 months. She felt well …

Progression of Left Valve Disease during Use of Dopaminergic Drugs

LS Barbosa, ACT Rodrigues, SN Pereira… - Arq Bras Cardiol …, 2017 - abcimaging.org
Cabergoline and bromocriptine are dopaminergic drugs deriving from ergot and used for
treating hyperprolactinemic idiopathic disorders or pituitary adenomas, whose mechanism of …

Bromocriptine/cabergoline

A D'Aloia - Reactions, 2014 - search.proquest.com
The man, who had a history of a surgically treated prolactinsecreting pituitary adenoma,
hypoadrenocorticism and panhypopituitarism, received treatment with bromocriptine 5 mg …

[引用][C] Bromocriptine/cabergoline

AM Faria - Reactions, 2016 - search.proquest.com
A 10-year-old boy developed exacerbation of migraine during treatment with bromocriptine
and cabergoline, which was successfully treated with topiramate. The boy, who was …

Drugs That Affect Autonomic Functions or the Extrapyramidal System

T Nakaki - Side Effects of Drugs Annual, 2017 - Elsevier
The adverse effects of drugs that affect autonomic functions or the extrapyramidal system are
reviewed based on literature published mainly from January, 2016 to December, 2016. As …

Drug intoxication leading to hypotension, nausea and anorexia: case report

V De Meyer - Reactions, 2016 - search.proquest.com
A 58-year-old man developed hypotension, nausea and anorexia due to cabergoline
intoxication. The man, who had a history of kidney transplants and peritoneal dialysis, had …

Cabergoline-induced manic episode: case report

RN Yüksel, Z Elyas Kaya, N Dilbaz… - Therapeutic …, 2016 - journals.sagepub.com
Cabergoline is an orally administered synthetic dopamine agonist that is used for the
treatment of hyperprolactinemia, Parkinson's disease and antipsychotic-induced prolactin …

[引用][C] First report of neuroleptic malignant syndrome after rapid discontinuation of bromocriptine: case report

J Reimer - Reactions, 2003 - Springer
The man, who had been receiving levodopa/benserazide and bromocriptine, had been
hospitalised with a deterioration of Parkinsonian symptoms due to poor medication …

[PDF][PDF] Cabergoline toxicity: A case report

DT Shah, KR Rana… - Indian Journal of Case …, 2022 - mansapublishers.com
DISCUSSION The patient was admitted with the adverse effects of the Cabergoline drug in
the form of rashes all over the body. After stopping the drug and starting treatment as …